Free Trial

Nautilus Biotechnology (NAUT) SEC Filings & 10K Form

Nautilus Biotechnology logo
$2.61
+0.01 (+0.38%)
(As of 11/1/2024 ET)

Recent Nautilus Biotechnology SEC Filings

DateFilerForm TypeView
09/25/2024
5:29 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:58 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
5:32 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:40 PM
Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
3:47 PM
Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:22 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
5:02 PM
EDELMAN JOSEPH (Reporting)
Nautilus Biotechnology (Issuer)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:03 PM
ALTMAN MICHAEL SETH (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:09 PM
McIlwain Matthew S (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:37 PM
Epperly Melissa B, (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:40 PM
Akinsanya Karen (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:24 PM
Nautilus Biotechnology (Issuer)
NAZEM FARZAD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:35 PM
Nautilus Biotechnology (Issuer)
Pande Vijay Satyanand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:12 PM
Nautilus Biotechnology (Filer)
Form ARS
03/11/2024
7:21 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
6:06 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
11:15 PM
Nautilus Biotechnology (Filer)
Form EFFECT
03/05/2024
3:52 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:42 PM
Mowry Anna (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:25 AM
Nautilus Biotechnology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2024
6:26 AM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:15 AM
Nautilus Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:03 AM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:04 AM
Nautilus Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/14/2023
3:17 PM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
8:18 PM
Nautilus Biotechnology (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAUT) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners